Loading companies…
Loading companies…
United Kingdom · Biotech · Healthtech
Develops full-spectrum microbiome therapeutics for gastrointestinal diseases including IBS
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | £19M | Scottish National Investment Bank — Role not disclosedThairm Bio — Role not disclosed |